Page last updated: 2024-11-05

neburon

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

neburon: structure in Merck Index, 9th ed, #6264 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11145
CHEMBL ID75410
CHEBI ID7491
SCHEMBL ID27181
SCHEMBL ID22130354
MeSH IDM0092401

Synonyms (45)

Synonym
BIDD:ER0535
CHEMBL75410
chebi:7491 ,
urea, n-butyl-n'-(3,4-dichlorophenyl)-n-methyl-
neburon
555-37-3
kloben
granurex
brn 2733280
neburex
einecs 209-096-0
1-n-butyl-3-(3,4-dichlorophenyl)-1-methylurea
3-(3,4-dichlorophenyl)-1-methyl-1-butylurea
neburea
kloben neburon
n-butyl-n'-(3,4-dichlorophenyl)-n-methylurea
epa pesticide chemical code 012001
1-butyl-3-(3,4-dichlorophenyl)-1-methylurea
caswell no. 594
urea, 1-butyl-3-(3,4-dichlorophenyl)-1-methyl-
neburon [ansi:bsi:iso]
3-(3,4-dichlorphenyl)-1-n-butyl-harnstoff [german]
3-butyl-1-(3,4-dichlorophenyl)-3-methylurea
unii-4mxn71654x
4mxn71654x ,
3-(3,4-dichlorphenyl)-1-n-butyl-harnstoff
FT-0603469
AKOS015888384
SCHEMBL27181
3-(3,4-dichlorophenyl)-1-methyl-1-n-butylurea
neburon [iso]
neburon [mi]
3-(3,4-dichlorophenyl)-1-n-butyl-1-methylurea
n-(3,4-dichlorophenyl)-n'-methyl-n'-butylurea
herbalt
CCGPUGMWYLICGL-UHFFFAOYSA-N
1-butyl-3-(3,4-dichlorophenyl)-1-methyl-urea
DTXSID4042200
neburon, pestanal(r), analytical standard
neburon 100 microg/ml in acetonitrile
pesticide3_neburon_c12h16cl2n2o_urea, n-butyl-n'-(3,4-dichlorophenyl)-n-methyl-
SCHEMBL22130354
Q22808466
Z56260372
neburon 10 microg/ml in acetonitrile
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
ureas
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID31516In vitro percentage inhibition against acyl coenzyme A:cholesterol acyltransferase derived from rat adrenals1989Journal of medicinal chemistry, Oct, Volume: 32, Issue:10
Potential antiatherosclerotic agents. 6. Hypocholesterolemic trisubstituted urea analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (57.14)18.7374
1990's2 (28.57)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.73 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]